CDH1 and melanoma: Studies in melanoma and hepatocellular carcinoma have linked Gli1 to vascular/capsular invasion, advanced tumor stage, and upregulation of matrix metalloprotease (MMP)-2 and MMP-9, while siRNA silencing of Gli1 successfully reduced invasion and increased E-cadherin expression [40, 41].